| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |